Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Chief Financial Officer Melanie Ross resigns as a director of the company with immediate effect and will leave the company outright on November 30. Abingdon Health says it expects to appoint an interim finance director shortly.
On Tuesday, Abingdon Health had reported a narrowed loss amid higher revenue and decreased costs, as it focuses on shifting away from Covid-19 testing products. Pretax loss in the financial year that ended on June 30 narrowed to GBP3.6 million from GBP21.6 million a year prior. Revenue climbed 43% to GBP4.0 million from GBP2.8 million. Cost of sales decreased to GBP2.0 million from GBP6.4 million, while administrative costs were 21% lower at GBP5.2 million from GBP6.6 million.
Current stock price: 10.35 pence, down 10% in London on Wednesday
12-month change: up 45%
By Greg Rosenvinge, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Abingdon Healt. (ABDX)